# ![@vanjohn10 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::28637628.png) @vanjohn10 John Vandermosten

John Vandermosten posts on X about $mdai, $plx, $cing, $lexx the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::28637628/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::28637628/c:line/m:interactions.svg)

- [--] Week [-----] +693%
- [--] Month [-----] +57%
- [--] Months [------] +190%
- [--] Year [------] +31%

### Mentions: [--] [#](/creator/twitter::28637628/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::28637628/c:line/m:posts_active.svg)

- [--] Week [--] +80%
- [--] Month [--] +92%
- [--] Months [---] +69%
- [--] Year [---] +124%

### Followers: [-----] [#](/creator/twitter::28637628/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::28637628/c:line/m:followers.svg)

- [--] Week [-----] +0.12%
- [--] Month [-----] +0.06%
- [--] Months [-----] +3.20%
- [--] Year [-----] +4.80%

### CreatorRank: [---------] [#](/creator/twitter::28637628/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::28637628/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  36.89% [stocks](/list/stocks)  20.49% [finance](/list/finance)  13.11% [exchanges](/list/exchanges)  4.1% [countries](/list/countries)  1.64% [agencies](/list/agencies)  0.82% [technology brands](/list/technology-brands)  0.82%

**Social topic influence**
[$mdai](/topic/$mdai) 23.77%, [$plx](/topic/$plx) #13, [$cing](/topic/$cing) #2, [$lexx](/topic/$lexx) 8.2%, [cingulate inc](/topic/cingulate-inc) #2, [ceo](/topic/ceo) 5.74%, [$radx](/topic/$radx) 5.74%, [burns](/topic/burns) 4.92%, [nasdaq](/topic/nasdaq) #882, [$hura](/topic/$hura) #10

**Top accounts mentioned or mentioned by**
[@spectralmdai](/creator/undefined) [@protalixbio](/creator/undefined) [@spectralmdais](/creator/undefined) [@lexariabiocorp](/creator/undefined) [@chrislplast](/creator/undefined) [@tuhurabio](/creator/undefined) [@cingulateinc](/creator/undefined) [@cingulateincs](/creator/undefined) [@teamradiopharm](/creator/undefined) [@lantheusnews](/creator/undefined) [@zackssmallcap](/creator/undefined) [@geovaxnews](/creator/undefined) [@dyadicinc](/creator/undefined) [@ligandlgnd](/creator/undefined) [@acuamarkdxs](/creator/undefined) [@davidbautz](/creator/undefined) [@trincapitals](/creator/undefined) [@rob](/creator/undefined) [@tuhurabios](/creator/undefined) [@forbespicks45](/creator/undefined)

**Top assets mentioned**
[Cingulate Inc. (CING)](/topic/$cing) [Lantheus Holdings, Inc (LNTH)](/topic/$lnth) [Ligand Pharmaceuticals Inc. (LGND)](/topic/$lgnd) [Trinity Capital Inc. (TRIN)](/topic/$trin) [Rani Therapeutics Holdings, Inc. (RANI)](/topic/$rani) [TRON (TRX)](/topic/$trx) [SBC Medical Group Holdings Incorporated (SBC)](/topic/$sbc) [Bitgesell (BGL)](/topic/$bgl) [IN8bio, Inc. (INAB)](/topic/$inab) [ADHD (ADHD)](/topic/$adhd) [Morgan Stanley (MS)](/topic/morgan-stanley) [AT&T Inc. (T)](/topic/$t) [Colgate-Palmolive Company (CL)](/topic/$cl) [Texas Instruments (TXN)](/topic/$txn) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Advanced Micro Devices (AMD)](/topic/advanced-micro-devices) [Tenet Healthcare Corporation New (THC)](/topic/$thc)
### Top Social Posts
Top posts by engagements in the last [--] hours

"We speak with @trincapital's Life Sciences Lead @Rob Lake. He explains the components of return for private capital. $TRIN #LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics https://trinitycapital.com/life-sciences/ https://trinitycapital.com/life-sciences/"  
[X Link](https://x.com/vanjohn10/status/1995905721628606956)  2025-12-02T17:19Z [----] followers, [---] engagements


"As we advance to CTx-1301s 31May26 target action date @CingulateInc SVP of Market Access Rick Arce explains how to get payors on board. $CING #PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #DrugDelivery #ExtendedRelease #Dexmethylphenidate https://youtube.com/shorts/T-fYVAZUZW8feature=share https://youtube.com/shorts/T-fYVAZUZW8feature=share"  
[X Link](https://x.com/anyuser/status/2020299814466998665)  2026-02-08T00:53Z [----] followers, [---] engagements


"More Ph1b data from @LexariaBioCorp for GLP-1 agonist study: *Rough parity reported between the arms for glucose cholestrol & LDLs *DHT-CBD showed reduced blood pressure This + other data suggest the best way forward to be DHT-Rybelsus vs DHT-semaglutide $LEXX https://lexariabioscience.com/2025/12/30/lexaria-releases-additional-results-from-its-successful-phase-1b-study-glp-1-h24-4/ https://lexariabioscience.com/2025/12/30/lexaria-releases-additional-results-from-its-successful-phase-1b-study-glp-1-h24-4/"  
[X Link](https://x.com/anyuser/status/2006373668033532406)  2025-12-31T14:35Z [----] followers, [---] engagements


"CEO Dr James Bianco shares @TuhuraBio's work with the #FDA's Oncology Center of Excellence to construct a trial to satisfy requirements for accelerated & full approval of IFx-2.0 in Merkel Cell Carcinoma $HURA #TuhuraBio #Bioscience #LifeSciences #Oncology #DrugDiscovery #TargetedTherapies https://youtube.com/shorts/eeS09w14hysfeature=share https://youtube.com/shorts/eeS09w14hysfeature=share"  
[X Link](https://x.com/anyuser/status/2009346044136751235)  2026-01-08T19:26Z [----] followers, [---] engagements


"As we move towards CTx-1301s 31May26 target action date @CingulateInc CEO Shane Schaffer describes payors reactions to the medicine. $CING #PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #PDUFA #NDAFails https://youtube.com/shorts/nIzinPJG1lcfeature=share https://youtube.com/shorts/nIzinPJG1lcfeature=share"  
[X Link](https://x.com/vanjohn10/status/2019783697054965773)  2026-02-06T14:42Z [----] followers, [---] engagements


"EVP and Chief Commercial Officer Bryan Downey explains Indegenes role in @CingulateInc's commercialization efforts for CTx-1301 in ADHD. $CING #PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #ControlledRelease #Dexmethylphenidate https://youtube.com/shorts/UnnYMnb9w9gfeature=share https://youtube.com/shorts/UnnYMnb9w9gfeature=share"  
[X Link](https://x.com/anyuser/status/2020904963187081327)  2026-02-09T16:57Z [----] followers, [---] engagements


"EVP & Chief Commercial Officer Bryan Downey explains @CingulateInc's commercialization efforts and how young adult women fit in as patients caregivers & decision makers for family health care. $CING CTx-1301 #ADHD #PTR #NASDAQ #Biotech #BioPharma #FDA #PDUFA #NDA https://youtube.com/shorts/UVKJ3rlIihMfeature=share https://twitter.com/i/web/status/2021705514069967350 https://youtube.com/shorts/UVKJ3rlIihMfeature=share https://twitter.com/i/web/status/2021705514069967350"  
[X Link](https://x.com/vanjohn10/status/2021705514069967350)  2026-02-11T21:58Z [----] followers, [---] engagements


"@Protalix_Bio receives positive opinion on [--] week dosing of Elfabrio in Europe vs the [--] now approved in Fabry disease. Follows re-examination request. If EC approves $PLX eligible for $25mm milestone. We discuss here: PR: https://ir.protalix.com/news-releases/news-release-details/chiesi-global-rare-diseases-and-protalix-biotherapeutics-4 https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_12222025_PLX_Vandermosten.pdf https://ir.protalix.com/news-releases/news-release-details/chiesi-global-rare-diseases-and-protalix-biotherapeutics-4"  
[X Link](https://x.com/vanjohn10/status/2017331391206142221)  2026-01-30T20:17Z [----] followers, [---] engagements


"actually here is the link to where we discuss the CHMP opinion: https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_PLX_Vandermosten.pdf @Protalix_Bio receives positive opinion on [--] week dosing of Elfabrio in Europe vs the [--] now approved in Fabry disease. Follows re-examination request. If EC approves $PLX eligible for $25mm milestone. We discuss here: https://t.co/rvutgm9D9B PR: https://t.co/LFPtBfoQ9U https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_PLX_Vandermosten.pdf @Protalix_Bio receives positive opinion on [--] week dosing of Elfabrio in"  
[X Link](https://x.com/anyuser/status/2018110078369309102)  2026-02-01T23:51Z [----] followers, [---] engagements


"TuHURA to present at Oppenheimer Life Sciences Conference 26Feb $HURA To prepare check out our talk w/ CEO Dr Bianco on ADCs https://youtu.be/brUktlLlD74 https://finance.yahoo.com/news/tuhura-biosciences-present-oppenheimer-36th-124500722.html https://youtu.be/brUktlLlD74 https://finance.yahoo.com/news/tuhura-biosciences-present-oppenheimer-36th-124500722.html"  
[X Link](https://x.com/vanjohn10/status/2021949436851531865)  2026-02-12T14:08Z [----] followers, [---] engagements


"Rani Therapeutics' #CEO Talat Imran describes the Rani Pill & how it works along with listing some of the leading biologics that are appropriate $RANI partners. #Biotech #BioPharma #PharmaInnovation #DrugDevelopment #ClinicalTrials #MedTech #HealthTech #LifeSciences #FutureOfMedicine #Therapeutics https://twitter.com/i/web/status/1995211006478626888 https://twitter.com/i/web/status/1995211006478626888"  
[X Link](https://x.com/vanjohn10/status/1995211006478626888)  2025-11-30T19:19Z [----] followers, [----] engagements


"Dr. Ann Childress principal investigator on @CingulateInc's CTx-1301 trials explains the importance identifying the optimal dose for ADHD patients. $CING https://youtu.be/K5rPEw7OJLI https://youtu.be/K5rPEw7OJLI"  
[X Link](https://x.com/vanjohn10/status/1998766990530371755)  2025-12-10T14:49Z [----] followers, [---] engagements


"Dr. Ann Childress principal investigator on @CingulateInc's CTx-1301 trials shares other data reported from the study. Notably & in contrast to the pediatric study the adult study was mostly female. $CING https://youtu.be/Rl_co75JDB8 https://youtu.be/Rl_co75JDB8"  
[X Link](https://x.com/vanjohn10/status/2000252504488161291)  2025-12-14T17:12Z [----] followers, [---] engagements


"@ZacksSmallCap highlights its best picks for [----]. See our clip below for our thoughts on $TRX $SBC $CBAT $TNXP $DYLLF $HITI $BGL $RADX https://youtu.be/KCDybCJKrKk https://youtu.be/KCDybCJKrKk"  
[X Link](https://x.com/vanjohn10/status/2015801032631107861)  2026-01-26T14:56Z [----] followers, [---] engagements


"@LexariaBioCorp announces final results from pilot study #5 *DehydraTECH liraglutide vs Saxenda DHT arm had fewer adverse events seeking path to oral formulation of DHT-liraglutide $LEXX PR summarizes study details https://lexariabioscience.com/2026/02/05/lexaria-announces-positive-final-results-from-human-pilot-study-5/ https://lexariabioscience.com/2026/02/05/lexaria-announces-positive-final-results-from-human-pilot-study-5/"  
[X Link](https://x.com/vanjohn10/status/2019485108558840312)  2026-02-05T18:55Z [----] followers, [---] engagements


"@TuhuraBio presented its Delta Opioid Receptor findings at the American Society of Hematology (ASH) annual meeting in December [----]. CEO Dr James Bianco explains. https://youtu.be/wPTPhbdw43Q https://youtu.be/wPTPhbdw43Q"  
[X Link](https://x.com/vanjohn10/status/2020292578026127624)  2026-02-08T00:24Z [----] followers, [--] engagements


"@TuhuraBio CEO Dr. James Bianco explains the mechanism of action for the Delta Opioid Receptor which modifies the tumor microenvironment rather than targeting the tumor itself. $HURA #ImmunoOncology #CancerResearch #CancerImmunotherapy #ImmuneSuppression #MDSCs https://youtu.be/8xSUa9LjsNk https://youtu.be/8xSUa9LjsNk"  
[X Link](https://x.com/vanjohn10/status/2020664131955618187)  2026-02-09T01:00Z [----] followers, [---] engagements


"@CingulateInc CEO Shane Schaffer discusses the submission of the NDA for CTx-1301 and what to expect during the review process as we look towards the May 31st [----] PDUFA date. $CING https://youtube.com/shorts/xPHtsAUNwYc https://youtube.com/shorts/xPHtsAUNwYc"  
[X Link](https://x.com/vanjohn10/status/2021280684032000118)  2026-02-10T17:50Z [----] followers, [---] engagements


"Trinity Capitals Rob Lake looks at private capitals ability to stretch runway to achieve milestones while minimizing dilution $TRIN #LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation https://twitter.com/i/web/status/2000975630154760352 https://twitter.com/i/web/status/2000975630154760352"  
[X Link](https://x.com/vanjohn10/status/2000975630154760352)  2025-12-16T17:05Z [----] followers, [---] engagements


"@TuhuraBio receives Orphan Drug Designation for IFx-2.0 for Stage IIB to Stage IV cutaneous melanoma. $HURA https://ir.tuhurabio.com/news-events/press-releases/detail/35/tuhura-biosciences-received-fda-orphan-drug-designation-for-ifx-2-0-for-the-treatment-of-stage-iib-to-stage-iv-cutaneous-melanoma https://ir.tuhurabio.com/news-events/press-releases/detail/35/tuhura-biosciences-received-fda-orphan-drug-designation-for-ifx-2-0-for-the-treatment-of-stage-iib-to-stage-iv-cutaneous-melanoma"  
[X Link](https://x.com/vanjohn10/status/2019036499057222049)  2026-02-04T13:13Z [----] followers, [----] engagements


"Join Dr Bianco as he describes TuHURA Biosciences' IFx-2.0 program in Merkel cell carcinoma. $HURA https://youtu.be/TQpM99rULTI @TuhuraBio receives Orphan Drug Designation for IFx-2.0 for Stage IIB to Stage IV cutaneous melanoma. $HURA https://t.co/EWglq21vFO https://youtu.be/TQpM99rULTI @TuhuraBio receives Orphan Drug Designation for IFx-2.0 for Stage IIB to Stage IV cutaneous melanoma. $HURA https://t.co/EWglq21vFO"  
[X Link](https://x.com/vanjohn10/status/2019036635397267905)  2026-02-04T13:13Z [----] followers, [----] engagements


"@CingulateInc's SVP of Market Access Rick Arce makes the case for CTx-1301 to payors we move towards the May [--] [----] target action date. $CING #PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #DrugDelivery https://youtube.com/shorts/aKWRiPsWlcE https://youtube.com/shorts/aKWRiPsWlcE"  
[X Link](https://x.com/vanjohn10/status/2022333667620847872)  2026-02-13T15:34Z [----] followers, [---] engagements


"@Protalix_Bio reports [----] results. Call @ 8:30 am ET today $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-reports-fiscal-2024-105000104.html https://finance.yahoo.com/news/protalix-biotherapeutics-reports-fiscal-2024-105000104.html"  
[X Link](https://x.com/vanjohn10/status/1901591999410512080)  2025-03-17T11:10Z [----] followers, [--] engagements


"@Spectral_MDAI reports burn study data. DeepView vs Burn Physician results: Sensitivity-86.6% vs 40.8% Dice Score-68.5% vs 39.2% Specificity-61.2% vs 79.1% De Novo submission in 2Q:25 $MDAI https://finance.yahoo.com/news/spectral-ai-announces-successful-results-110000579.html https://finance.yahoo.com/news/spectral-ai-announces-successful-results-110000579.html"  
[X Link](https://x.com/vanjohn10/status/1901593467345588541)  2025-03-17T11:16Z [----] followers, [--] engagements


"IN8bio CEO William Ho will participate in the IO360 Conference 24-26Mar in Boston. $INAB https://finance.yahoo.com/news/in8bio-participate-11th-annual-immuno-120500823.html https://finance.yahoo.com/news/in8bio-participate-11th-annual-immuno-120500823.html"  
[X Link](https://x.com/vanjohn10/status/1902338067228160006)  2025-03-19T12:35Z [----] followers, [---] engagements


"@ForbesPicks45 @ChiesiGRD They are building up cash to support their development portfolio. As they move into later stage trials & add more candidates R&D will rise. Which Chiesi rumors are you referencing"  
[X Link](https://x.com/vanjohn10/status/1902349927071490355)  2025-03-19T13:22Z [----] followers, [--] engagements


"@DyadicInc gets CEPI funding award to develop protein-based vaccines with C1. $4.5mm Fondazione Biotecnopolo partner $DYAI https://finance.yahoo.com/news/dyadic-announces-funding-award-cepi-123000076.html https://finance.yahoo.com/news/dyadic-announces-funding-award-cepi-123000076.html"  
[X Link](https://x.com/vanjohn10/status/1902707464052613392)  2025-03-20T13:03Z [----] followers, [--] engagements


"@Spectral_MDAI files for IPO of its subsidiary Spectral IP. If successful will trade under the ticker $SMIP. S-1 filed: $MDAI PR: https://finance.yahoo.com/news/spectral-ai-announces-public-filing-200000736.html https://www.sec.gov/Archives/edgar/data/2042176/000121390025025266/ea0218945-04.htm https://finance.yahoo.com/news/spectral-ai-announces-public-filing-200000736.html https://www.sec.gov/Archives/edgar/data/2042176/000121390025025266/ea0218945-04.htm"  
[X Link](https://x.com/vanjohn10/status/1903091049435664696)  2025-03-21T14:27Z [----] followers, [--] engagements


"@Spectral_MDAI raises $8.5mm in debt & $2.7mm in equity. $MDAI debt facility has 2nd $6.5mm tranche available after FDA clearance. To support DeepView launch & commercialization. https://finance.yahoo.com/news/spectral-ai-raises-15-million-113000974.html https://finance.yahoo.com/news/spectral-ai-raises-15-million-113000974.html"  
[X Link](https://x.com/vanjohn10/status/1904151991669960878)  2025-03-24T12:43Z [----] followers, [--] engagements


"@Protalix_Bio to present @ iAccess virtual conference 25-26Mar. $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-present-iaccess-alpha-105000503.html https://finance.yahoo.com/news/protalix-biotherapeutics-present-iaccess-alpha-105000503.html"  
[X Link](https://x.com/vanjohn10/status/1904152895408197710)  2025-03-24T12:46Z [----] followers, [--] engagements


"@Spectral_MDAI reports [----] results *Call @ [--] pm ET $MDAI https://investors.spectral-ai.com/news-releases/news-release-details/spectral-ai-announces-2024-fourth-quarter-and-full-year https://investors.spectral-ai.com/news-releases/news-release-details/spectral-ai-announces-2024-fourth-quarter-and-full-year"  
[X Link](https://x.com/vanjohn10/status/1905363785440702928)  2025-03-27T20:58Z [----] followers, [--] engagements


"@LexariaBioCorp begins dosing human Study #5 comparing oral DehydraTECH-liraglutide to injectable Saxenda. $LEXX #LEXX #GLP1 #Biotech #Obesity https://finance.yahoo.com/news/lexarias-human-glp-1-study-130500653.html https://finance.yahoo.com/news/lexarias-human-glp-1-study-130500653.html"  
[X Link](https://x.com/vanjohn10/status/1907432812480753800)  2025-04-02T13:59Z [----] followers, [--] engagements


"@LexariaBioCorp Ph1b GLP1 study update: *Patient enrollment in all [--] study arms complete *24 patients/arm *Last patient in milestone met *Completion of treatment for study expected in [--] weeks $LEXX https://finance.yahoo.com/news/lexaria-updates-ongoing-human-study-131000178.html https://finance.yahoo.com/news/lexaria-updates-ongoing-human-study-131000178.html"  
[X Link](https://x.com/vanjohn10/status/1907816085446959284)  2025-04-03T15:22Z [----] followers, [--] engagements


"Grace Therapeutics & #FDA aligned on NDA submission details for GTx-104 which has completed Ph3 study in aneurysmal subarachnoid hemorrhage (aSAH) patients. NDA submission expected 2Q25. $GRCE https://finance.yahoo.com/news/grace-therapeutics-announces-alignment-fda-120000349.html https://finance.yahoo.com/news/grace-therapeutics-announces-alignment-fda-120000349.html"  
[X Link](https://x.com/vanjohn10/status/1909975724141724156)  2025-04-09T14:24Z [----] followers, [---] engagements


"Join @Ligand_LGND's #CEO Todd Davis & me as we discuss the anticipated spin out of Pelthos and its dermatology drug Zelsuvmi. $LGND https://youtu.be/2B7JQiCyaQo https://youtu.be/2B7JQiCyaQo"  
[X Link](https://x.com/vanjohn10/status/1910298754776805562)  2025-04-10T11:48Z [----] followers, [---] engagements


"@TuhuraBio presents anti-VISTA & IFx-Hu2.0 responses @AACR *25-30Apr *90% VISTA receptor occupancy at 1000mg dose *IFx-2.0 produced clinically meaningful anti-tumor responses and abscopal effect *$HURA-Kineta merger targeted to close 2Q:25 https://finance.yahoo.com/news/tuhura-biosciences-kineta-present-updated-120000006.html https://finance.yahoo.com/news/tuhura-biosciences-kineta-present-updated-120000006.html"  
[X Link](https://x.com/vanjohn10/status/1916836295185240531)  2025-04-28T12:46Z [----] followers, [--] engagements


"@Spectral_MDAI's burn diagnostic DeepView was introduced to participants @ the American Burn Association annual meeting 7-11Apr in Phoenix Included *practitioner feedback *independent product evaluation conducted by Newcastle Burn Center $MDAI https://finance.yahoo.com/news/burn-clinicians-present-positive-findings-200000474.html https://finance.yahoo.com/news/burn-clinicians-present-positive-findings-200000474.html"  
[X Link](https://x.com/vanjohn10/status/1917939547238805679)  2025-05-01T13:49Z [----] followers, [--] engagements


"@Spectral_MDAI to report 1Q:25 on 13May *Call @ [--] pm ET $MDAI https://finance.yahoo.com/news/spectral-ai-schedules-2025-first-200000065.html https://finance.yahoo.com/news/spectral-ai-schedules-2025-first-200000065.html"  
[X Link](https://x.com/vanjohn10/status/1919350989179486615)  2025-05-05T11:18Z [----] followers, [--] engagements


"@Protalix_Bio to report 1Q:25 on 9May *Call @ 8:30 am ET $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-announce-first-quarter-105000306.html https://finance.yahoo.com/news/protalix-biotherapeutics-announce-first-quarter-105000306.html"  
[X Link](https://x.com/vanjohn10/status/1919351837783711842)  2025-05-05T11:21Z [----] followers, [--] engagements


"@Protalix_Bio reports 1Q25 *Call @ 8:30 am ET *Revs of $10.1mm up on higher Elelyso sales *EPS ($0.05) $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-reports-first-quarter-105000133.html https://finance.yahoo.com/news/protalix-biotherapeutics-reports-first-quarter-105000133.html"  
[X Link](https://x.com/vanjohn10/status/1920799703630832056)  2025-05-09T11:15Z [----] followers, [---] engagements


"@Spectral_MDAI reports 1Q25 *R&D revenue of $6.7mm *Cash $14.1mm *Focused on FDA submission of DeepView in 1H25 *Guidance reiterated *Call @ [--] pm ET $MDAI https://finance.yahoo.com/news/spectral-ai-announces-2025-first-200500685.html https://finance.yahoo.com/news/spectral-ai-announces-2025-first-200500685.html"  
[X Link](https://x.com/vanjohn10/status/1922385178845958363)  2025-05-13T20:15Z [----] followers, [--] engagements


"@Protalix_Bio to present @ HCW Bioconnect conference *20May *NYC $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-present-3rd-annual-105000039.html https://finance.yahoo.com/news/protalix-biotherapeutics-present-3rd-annual-105000039.html"  
[X Link](https://x.com/vanjohn10/status/1923350281514864688)  2025-05-16T12:10Z [----] followers, [--] engagements


"@TeamRadiopharm signs supply agreement for non-carrier added Lutetium-177 ☢ with @ITM_Radiopharma. Lu-177 to be used with RAD204 RAD201 & RV01. $RADX https://finance.yahoo.com/news/itm-radiopharm-sign-supply-agreement-120000357.html https://finance.yahoo.com/news/itm-radiopharm-sign-supply-agreement-120000357.html"  
[X Link](https://x.com/vanjohn10/status/1924454908998119570)  2025-05-19T13:19Z [----] followers, [--] engagements


"@Spectral_MDAI research partners awarded Best Research Project using DeepView in diabetic foot ulcers. *RCSI Skin Wounds & Trauma *RCSI Connolly Hospital $MDAI https://finance.yahoo.com/news/spectral-ai-research-partner-using-120000332.html https://finance.yahoo.com/news/spectral-ai-research-partner-using-120000332.html"  
[X Link](https://x.com/vanjohn10/status/1924836355747557686)  2025-05-20T14:35Z [----] followers, [--] engagements


"@Spectral_MDAI's DeepView System featured in Burns: The Journal of the International Society for Burn Injuries. Achieves 95.3% accuracy vs traditional subjective assessments by physicians. $MDAI https://finance.yahoo.com/news/deepview-system-achieves-95-3-120000484.html https://finance.yahoo.com/news/deepview-system-achieves-95-3-120000484.html"  
[X Link](https://x.com/vanjohn10/status/1927364041523048945)  2025-05-27T13:59Z [----] followers, [--] engagements


"@Spectral_MDAI voting results from annual meeting of stockholders $MDAI https://finance.yahoo.com/news/spectral-ai-announces-voting-results-120000820.html https://finance.yahoo.com/news/spectral-ai-announces-voting-results-120000820.html"  
[X Link](https://x.com/vanjohn10/status/1929603659895111900)  2025-06-02T18:18Z [----] followers, [--] engagements


"@Spectral_MDAI appoints Stanley Micek as COO Promoted from interim COO $MDAI https://finance.yahoo.com/news/spectral-ai-announces-appointment-stanley-120000052.html https://finance.yahoo.com/news/spectral-ai-announces-appointment-stanley-120000052.html"  
[X Link](https://x.com/vanjohn10/status/1929608477888204901)  2025-06-02T18:38Z [----] followers, [--] engagements


"We initiated @TeamRadiopharm @ $12.50/ADS. $RADX combines targeting capabilities of precision oncology & radioisotope lethality to improve cancer outcomes. Imaging candidates provide improved tumor identification & location accuracy over existing technologies. https://youtu.be/XOwVpXIhLf8 https://youtu.be/XOwVpXIhLf8"  
[X Link](https://x.com/vanjohn10/status/1929634933506822262)  2025-06-02T20:23Z [----] followers, [---] engagements


"@TeamRadiopharm reports preclinical data for RV01 program targeting B7H3 + Lu177 radioisotope *favorable biodistribution *high tumor uptake *study completion will allow for IND submission mid'25 $RADX https://finance.yahoo.com/news/radiopharm-theranostics-reports-preclinical-lu177-120000675.html https://finance.yahoo.com/news/radiopharm-theranostics-reports-preclinical-lu177-120000675.html"  
[X Link](https://x.com/vanjohn10/status/1929886666140921989)  2025-06-03T13:03Z [----] followers, [--] engagements


"@TeamRadiopharm doses 1st patient in RAD202 trial to identify Ph2 dose *HER2+ solid tumors *Lu-177 isotope $RADX https://finance.yahoo.com/news/radiopharm-theranostics-doses-first-patient-120000204.html https://finance.yahoo.com/news/radiopharm-theranostics-doses-first-patient-120000204.html"  
[X Link](https://x.com/vanjohn10/status/1930242663103508743)  2025-06-04T12:38Z [----] followers, [--] engagements


"#ADHD medications have long suffered from a short duration of action exposing patients to rebound symptoms. @CingulateInc addresses this with CTx-1301's precision timed release technology. $CING #CEO Shane Schaffer delves into the details in this clip. https://youtu.be/yhQsbS9bUpQ https://youtu.be/yhQsbS9bUpQ"  
[X Link](https://x.com/vanjohn10/status/1932095903231295830)  2025-06-09T15:22Z [----] followers, [----] engagements


"See our recent clip on our initiation of $RADX: Initiation link: https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_05122025_RADX_Vandermosten.pdf https://youtu.be/XOwVpXIhLf8 #FDA grants @TeamRadiopharm's RAD101 fast track designation *RAD101 images brain metastases *$RADX may be eligible for more frequent FDA meetings rolling review & priority review https://t.co/L33GXbPtyi https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_05122025_RADX_Vandermosten.pdf https://youtu.be/XOwVpXIhLf8 #FDA grants @TeamRadiopharm's RAD101 fast track designation *RAD101 images"  
[X Link](https://x.com/vanjohn10/status/1932782943916687711)  2025-06-11T12:52Z [----] followers, [---] engagements


"@LexariaBioCorp highlights efficacy & reduction in adverse events of DehydraTECH + GLP-1s. Results from GLP-1-H25-5 further clarify regulatory pathway. $LEXX may develop liraglutide capsule via 505b2. https://finance.yahoo.com/news/lexarias-dehydratech-liraglutide-human-glp-130500968.html https://finance.yahoo.com/news/lexarias-dehydratech-liraglutide-human-glp-130500968.html"  
[X Link](https://x.com/vanjohn10/status/1932803691142115382)  2025-06-11T14:14Z [----] followers, [--] engagements


"@LexariaBioCorp announces that the GLP-1-H25-5 human study comparing oral DehydraTECH-liraglutide capsules with injected Saxenda is complete. Partial results available. $LEXX https://finance.yahoo.com/news/lexaria-bioscience-announces-completion-glp-131535915.html https://finance.yahoo.com/news/lexaria-bioscience-announces-completion-glp-131535915.html"  
[X Link](https://x.com/vanjohn10/status/1933207808683462996)  2025-06-12T17:00Z [----] followers, [--] engagements


"Grace Therapeutics Inc. will soon submit its sNDA to the #FDA for approval of injectable nimodipine for use in aSAH patients. $GRCE Report: https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_06052025_GRCE_Vandermosten.pdf https://youtu.be/LEVS7GYQqpI https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_06052025_GRCE_Vandermosten.pdf https://youtu.be/LEVS7GYQqpI"  
[X Link](https://x.com/vanjohn10/status/1933575748910194952)  2025-06-13T17:22Z [----] followers, [---] engagements


"See our recent video summary for reasons to own $GRCE: Associated research report: https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_06052025_GRCE_Vandermosten.pdf https://youtu.be/LEVS7GYQqpI Grace Therapeutics reports FY2025 results NDA on track for 1H25 submission [----] cash burn: ($14.9) mm $GRCE https://t.co/0gzEeknFy1 https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_06052025_GRCE_Vandermosten.pdf https://youtu.be/LEVS7GYQqpI Grace Therapeutics reports FY2025 results NDA on track for 1H25 submission [----] cash burn: ($14.9) mm $GRCE https://t.co/0gzEeknFy1"  
[X Link](https://x.com/vanjohn10/status/1937147375178448961)  2025-06-23T13:54Z [----] followers, [---] engagements


"Shareholders approve @TuhuraBio & @kinetabio merger. It should close very soon adding an anti-VISTA mAb to $HURA's arsenal. Also approved: *authorized shares to 200mm *reincorporation to DE https://finance.yahoo.com/news/tuhura-biosciences-inc-kineta-inc-210000594.html https://finance.yahoo.com/news/tuhura-biosciences-inc-kineta-inc-210000594.html"  
[X Link](https://x.com/vanjohn10/status/1937502378128728330)  2025-06-24T13:25Z [----] followers, [--] engagements


"@TeamRadiopharm signs Terbium supply agreement with Cyclotek to support its RAD402 Ph1 clinical trial in prostate cancer. RAD402 is an anti-Kallikrein Related Peptidase [--] (KLK3) monoclonal antibody radiotherapeutic. $RADX https://finance.yahoo.com/news/radiopharm-theranostics-cyclotek-sign-clinical-120000695.html https://finance.yahoo.com/news/radiopharm-theranostics-cyclotek-sign-clinical-120000695.html"  
[X Link](https://x.com/vanjohn10/status/1937512142011265083)  2025-06-24T14:04Z [----] followers, [--] engagements


"Grace Therapeutics submits NDA to #FDA for GTx-104 *For treatment of aneurysmal Subarachnoid Hemorrhage *NDA acceptance will trigger warrant call *Acceptance expected in next [--] days $GRCE https://finance.yahoo.com/news/grace-therapeutics-announces-submission-drug-120000705.html https://finance.yahoo.com/news/grace-therapeutics-announces-submission-drug-120000705.html"  
[X Link](https://x.com/vanjohn10/status/1937875118333526189)  2025-06-25T14:06Z [----] followers, [---] engagements


"@achievelifesci announces: *Submission of NDA for cytisinicline in smoking cessation *Commercialization partnership with Omnicom *Proposed public offering Smokin or not.🚭 https://achievelifesciences.com/achieve-announces-proposed-underwritten-public-offering-2/ https://achievelifesciences.com/achieve-announces-omnicom-partnership-to-execute-potential-new-nicotine-dependence-treatment-launch/ https://achievelifesciences.com/achieve-announces-cytisinicline-nda-submission/ https://achievelifesciences.com/achieve-announces-proposed-underwritten-public-offering-2/"  
[X Link](https://x.com/vanjohn10/status/1938336253277294776)  2025-06-26T20:39Z [----] followers, [--] engagements


"@Protalix_Bio added to Russell [----] & [----] indices. Effective 27Jun25. $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-added-russell-3000-105000090.html https://finance.yahoo.com/news/protalix-biotherapeutics-added-russell-3000-105000090.html"  
[X Link](https://x.com/vanjohn10/status/1940403311137665365)  2025-07-02T13:32Z [----] followers, [--] engagements


"@Spectral_MDAI submits De Novo 501k marketing clearance application to FDA for the DeepView Burn Diagnostic. $MDAI Dr Lewis explains how DeepView can improve burn diagnosis. https://youtu.be/9Wb8qGZNSrE https://finance.yahoo.com/news/spectral-ai-announces-submission-fda-120000694.html https://youtu.be/9Wb8qGZNSrE https://finance.yahoo.com/news/spectral-ai-announces-submission-fda-120000694.html"  
[X Link](https://x.com/vanjohn10/status/1940404255892124127)  2025-07-02T13:36Z [----] followers, [--] engagements


"@CingulateInc appoints Nilay Patel JD as Chief Legal Officer in advance of CTx-1301 submission to the FDA and commercialization upon approval. Nilay held legal roles at Grifols & Life Sciences Law PLLC. $CING $ADHD https://finance.yahoo.com/news/cingulate-appoints-nilay-patel-chief-120000929.html https://finance.yahoo.com/news/cingulate-appoints-nilay-patel-chief-120000929.html"  
[X Link](https://x.com/vanjohn10/status/1942929731952718107)  2025-07-09T12:52Z [----] followers, [---] engagements


"We speak with @ChrisLPlast a burn surgeon at The Newcastle Upon Tyne Hospitals about a variety of topics in the burn wound space including the DeepView burn diagnostic AI and the most common types of burns. $MDAI @Spectral_MDAI https://youtu.be/ani1r1S1thg https://youtu.be/ani1r1S1thg"  
[X Link](https://x.com/vanjohn10/status/1943299949824766068)  2025-07-10T13:23Z [----] followers, [---] engagements


"How does AI help providers improve burn care @ChrisLPlast PhD shares his thoughts. #ameriburn #nbaw @ameriburn #plasticsurgery #health #scars #skincare #FDA #fire #healing #skin #surgery #medtech #medicaldevices #healthtech https://youtu.be/9Wb8qGZNSrEsi=GEeoGTe3O7C0OVBx https://youtu.be/9Wb8qGZNSrEsi=GEeoGTe3O7C0OVBx"  
[X Link](https://x.com/vanjohn10/status/1943665801069764747)  2025-07-11T13:36Z [----] followers, [--] engagements


"Join Unboxing Biotech & burn surgeon @ChrisLPlast in this provocatively titled fireside🔥chat where we explore the most common types of burns & how treatment differs around the globe. We examine @Spectral_MDAI's DeepView diagnostic & how it compares to standard of care. $MDAI https://youtu.be/ani1r1S1thg https://youtu.be/ani1r1S1thg"  
[X Link](https://x.com/vanjohn10/status/1944752349999763628)  2025-07-14T13:34Z [----] followers, [---] engagements


"Link to $RANI abstract for RT-114 a GLP-1/GLP-2 receptor agonist delivered via a robotic pill in an animal study. https://www.abstractsonline.com/pp8/#/20942/presentation/7790 Rani Therapeutics to present RT-114 data at ENDO [----]. Presentation today @ [--] pm in SFO by Dr Anvesh Dasari Poster available 12-15Jul. $RANI https://t.co/ndePkgnZBI https://www.abstractsonline.com/pp8/#/20942/presentation/7790 Rani Therapeutics to present RT-114 data at ENDO [----]. Presentation today @ [--] pm in SFO by Dr Anvesh Dasari Poster available 12-15Jul. $RANI https://t.co/ndePkgnZBI"  
[X Link](https://x.com/vanjohn10/status/1945119022523011362)  2025-07-15T13:51Z [----] followers, [---] engagements


"Portability has been a trend in all parts of our lives and work. Now this migration has come to burn diagnostics. Join @ChrisLPlast to review @Spectral_MDAI's Snapshot M mobile burn diagnostic. $MDAI https://youtu.be/p_HmDknt-sk https://youtu.be/p_HmDknt-sk"  
[X Link](https://x.com/vanjohn10/status/1945123074711466006)  2025-07-15T14:07Z [----] followers, [---] engagements


"@ChrisLPlast authored an article recently published in the journal Burns detailing the findings from @Spectral_MDAIs pivotal trial evaluating the DeepView burn diagnostic. Catch the highlights here. $MDAI https://youtu.be/cPZpazOPFgY https://youtu.be/cPZpazOPFgY"  
[X Link](https://x.com/vanjohn10/status/1945447395971526886)  2025-07-16T11:36Z [----] followers, [--] engagements


"DehydraTECH developer @LexariaBioCorp files FY 3Q25 10-Q. 3Q revs of $174k from Premier & net loss ($3.8)mm. Updated report coming shortly. $LEXX https://s3.amazonaws.com/sec.irpass.cc/2978/0001640334-25-001195.pdf https://s3.amazonaws.com/sec.irpass.cc/2978/0001640334-25-001195.pdf"  
[X Link](https://x.com/vanjohn10/status/1945469816661250284)  2025-07-16T13:05Z [----] followers, [--] engagements


"We look at the unmet needs in burn diagnosis with burn surgeon @ChrisLPlast who provides his opinion on DeepView's ease of use. @Spectral_MDAI $MDAI https://youtu.be/FJ-Y1T6-W_s https://youtu.be/FJ-Y1T6-W_s"  
[X Link](https://x.com/vanjohn10/status/1945819329770954862)  2025-07-17T12:14Z [----] followers, [---] engagements


"We speak with @ChrisLPlast who authored an article published in the journal Burns detailing the findings from @Spectral_MDAIs pivotal trial evaluating the DeepView burn diagnostic. $MDAI https://youtu.be/0B2GxNKUDkM https://youtu.be/0B2GxNKUDkM"  
[X Link](https://x.com/vanjohn10/status/1946216534499614956)  2025-07-18T14:32Z [----] followers, [---] engagements


"@Protalix_Bio will transition to a new CFO over the next month. Gilad Mamlok will take the financial reins of the company on 24Aug. $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-appoints-gilad-mamlok-105000736.html https://finance.yahoo.com/news/protalix-biotherapeutics-appoints-gilad-mamlok-105000736.html"  
[X Link](https://x.com/vanjohn10/status/1947290640858980385)  2025-07-21T13:40Z [----] followers, [--] engagements


"@Geovax_News revenue from its Mpox & smallpox vaccine could be sooner than expected based on EMA feedback. A Ph3 immuno-bridging study may provide sufficient data to support an MAA under the EU's centralized procedure. $GOVX https://finance.yahoo.com/news/geovax-highlights-ema-regulatory-milestone-130000889.html https://finance.yahoo.com/news/geovax-highlights-ema-regulatory-milestone-130000889.html"  
[X Link](https://x.com/vanjohn10/status/1947291624653897804)  2025-07-21T13:44Z [----] followers, [---] engagements


"@LantheusNews completes Life Molecular Imaging acquisition & appoints Dr Ludger Dinkelborg as R&D head. $LNTH gains amyloid imaging agent Neuraceq. https://finance.yahoo.com/news/lantheus-completes-acquisition-life-molecular-110000882.html https://finance.yahoo.com/news/lantheus-completes-acquisition-life-molecular-110000882.html"  
[X Link](https://x.com/vanjohn10/status/1947625322545090813)  2025-07-22T11:50Z [----] followers, [--] engagements


"@ChrisLPlast authored an article published in the journal Burns detailing the findings from @Spectral_MDAIs trial evaluating DeepView burn diagnostic. Dr Lewis reviews the risks of underdiagnosing and overdiagnosing burns. $MDAI https://youtu.be/mbc0isP30iE https://youtu.be/mbc0isP30iE"  
[X Link](https://x.com/vanjohn10/status/1947683394847924558)  2025-07-22T15:41Z [----] followers, [--] engagements


"@LantheusNews to report 2Q25 results on 6Aug. Call @ [--] am ET $LNTH https://finance.yahoo.com/news/lantheus-host-second-quarter-2025-120000348.html https://finance.yahoo.com/news/lantheus-host-second-quarter-2025-120000348.html"  
[X Link](https://x.com/vanjohn10/status/1948000017207218620)  2025-07-23T12:39Z [----] followers, [---] engagements


"@Ligand_LGND to report 2Q results 7Aug *Call @ 8:30 am ET $LGND https://finance.yahoo.com/news/ligand-report-second-quarter-2025-110000111.html https://finance.yahoo.com/news/ligand-report-second-quarter-2025-110000111.html"  
[X Link](https://x.com/vanjohn10/status/1948368252045807731)  2025-07-24T13:02Z [----] followers, [--] engagements


"@LexariaBioCorp highlights the GLP-1 agonist side effect profile of DehydraTECH formulated GLP-1s vs approved versions of the drug. An important hurdle to patient use are the unpleasant associated side effects. DehydraTECH may help. $LEXX https://finance.yahoo.com/news/lexarias-dehydratech-technology-potential-unlock-132500022.html https://finance.yahoo.com/news/lexarias-dehydratech-technology-potential-unlock-132500022.html"  
[X Link](https://x.com/vanjohn10/status/1950541053687169442)  2025-07-30T12:56Z [----] followers, [---] engagements


"@Spectral_MDAI to report 2Q results 12Aug Call @ [--] pm ET $MDAI https://finance.yahoo.com/news/spectral-ai-schedules-2025-second-120000477.html https://finance.yahoo.com/news/spectral-ai-schedules-2025-second-120000477.html"  
[X Link](https://x.com/vanjohn10/status/1950557935605543033)  2025-07-30T14:03Z [----] followers, [--] engagements


"Yesterday @DyadicInc announced a common stock offering. $DYAI priced 6.05mm shares today @ 95c. Gross proceeds of $5.75mm expected. 1Aug closing. https://dyadic.com/update-dyadic-international-inc-announces-pricing-of-public-offering-of-6052000-shares-of-common-stock/ https://dyadic.com/update-dyadic-international-inc-announces-pricing-of-public-offering-of-6052000-shares-of-common-stock/"  
[X Link](https://x.com/vanjohn10/status/1950920198724214823)  2025-07-31T14:03Z [----] followers, [---] engagements


"@LantheusNews reports 2Q25 results *Revs $378mm *adj EPS $1.57 *Rev guidance reduced by 4-5% & EPS by $1 *Call @ [--] am ET $LNTH https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-reports-second-quarter-2025-financial-results-and https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-reports-second-quarter-2025-financial-results-and"  
[X Link](https://x.com/vanjohn10/status/1953050329571864796)  2025-08-06T11:07Z [----] followers, [---] engagements


"Following statements by RFK as Secretary of HHS on eliminating mRNA vaccine @Geovax_News highlights its multi-antigen MVA vaccine candidate as an attractive alternative. $GOVX CEO Dodd notes that its Covid vaccine align with HHS priorities. https://finance.yahoo.com/news/geovax-comments-hhs-mrna-vaccine-130000057.html https://finance.yahoo.com/news/geovax-comments-hhs-mrna-vaccine-130000057.html"  
[X Link](https://x.com/vanjohn10/status/1953455099163852979)  2025-08-07T13:56Z [----] followers, [--] engagements


"@Protalix_Bio to report 2Q on 14Aug *Call at 8:30 am ET that morning $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-announce-second-quarter-165300213.html https://finance.yahoo.com/news/protalix-biotherapeutics-announce-second-quarter-165300213.html"  
[X Link](https://x.com/vanjohn10/status/1953776506334753066)  2025-08-08T11:13Z [----] followers, [--] engagements


"@Ligand_LGND prices $400mm convertible issuance *.75% yield *$195 conversion price *close expected 14Aug *net proceeds: $387mm *hedge cost: $40mm *$15mm equity repurchase $LGND https://finance.yahoo.com/news/ligand-announces-pricing-400-million-034600830.html https://finance.yahoo.com/news/ligand-announces-pricing-400-million-034600830.html"  
[X Link](https://x.com/vanjohn10/status/1955239532380455367)  2025-08-12T12:06Z [----] followers, [--] engagements


"@Spectral_MDAI reports 2Q *R&D revenue of $5.1mm *Cash @ $10.5mm *$2.1mm operating loss *Call @ [--] pm ET $MDAI https://investors.spectral-ai.com/news-releases/news-release-details/spectral-ai-announces-2025-second-quarter-financial-results https://investors.spectral-ai.com/news-releases/news-release-details/spectral-ai-announces-2025-second-quarter-financial-results"  
[X Link](https://x.com/vanjohn10/status/1955363431957270919)  2025-08-12T20:19Z [----] followers, [--] engagements


"@Protalix_Bio reports 2Q *Revs of $15.7mm vs our $11.6 *call @ 8:30 am ET $PLX https://ir.protalix.com/news-releases/news-release-details/protalix-biotherapeutics-reports-second-quarter-2025-financial https://ir.protalix.com/news-releases/news-release-details/protalix-biotherapeutics-reports-second-quarter-2025-financial"  
[X Link](https://x.com/vanjohn10/status/1955946286110200282)  2025-08-14T10:55Z [----] followers, [---] engagements


"@LexariaBioCorp announces last patient last visit for its Phase Ib GLP-1 study. This follows interim results that were reported in July showing reduction in side effects for DHT-formulated semaglutide vs Rybelsus. $LEXX https://lexariabioscience.com/2025/07/28/lexaria-provides-positive-interim-results-on-partial-8-week-data-from-phase-1b-glp-1-h24-4-study/ https://lexariabioscience.com/2025/07/28/lexaria-provides-positive-interim-results-on-partial-8-week-data-from-phase-1b-glp-1-h24-4-study/"  
[X Link](https://x.com/vanjohn10/status/1956380417033904338)  2025-08-15T15:40Z [----] followers, [--] engagements


"#ICYMI we had a broad conversation with @Spectral_MDAI's founder and chairman Dr. J. Michael DiMaio about AI how it is developed in diagnostic devices and the importance of China in healthcare among other topics. $MDAI https://lnkd.in/g8GVpez3 https://lnkd.in/g8GVpez3"  
[X Link](https://x.com/vanjohn10/status/1958909774206005658)  2025-08-22T15:10Z [----] followers, [---] engagements


"Join @Spectral_MDAI's Chairman of the Board Dr J Michael DiMaio to explore trends in the life sciences industry DeepView's potential the history of multispectral analysis and a deeper look into recent research. $MDAI https://youtu.be/cGktsfcfYSM https://youtu.be/cGktsfcfYSM"  
[X Link](https://x.com/vanjohn10/status/1959969178145656843)  2025-08-25T13:20Z [----] followers, [---] engagements


"Azitra doses 1st patient in Ph1/2 ATR04 trial in patients with EGFRi associated rash $AZTR https://finance.yahoo.com/news/azitra-inc-announces-first-patient-121000665.html https://finance.yahoo.com/news/azitra-inc-announces-first-patient-121000665.html"  
[X Link](https://x.com/vanjohn10/status/1960773664275595287)  2025-08-27T18:37Z [----] followers, [---] engagements


"Finance Focus & Finish: @Spectral_MDAI's Chairman of the Board Dr J Michael DiMaio explains the four Fs that he applies to $MDAI as it moves through the regulatory process and eventual commercialization of the DeepView burn diagnostic https://youtu.be/R6RdtHfjs98 https://youtu.be/R6RdtHfjs98"  
[X Link](https://x.com/vanjohn10/status/1961059551853081042)  2025-08-28T13:33Z [----] followers, [---] engagements


"With @Spectral_MDAI's founder & chairman Dr J Michael DiMaio we have a chance to dig deeper into $MDAI's application to the FDA look at commercialization with BARDA & DeepView's other possible indications. https://youtu.be/25nbD9FZIjs https://youtu.be/25nbD9FZIjs"  
[X Link](https://x.com/vanjohn10/status/1962237346599890979)  2025-08-31T19:33Z [----] followers, [---] engagements


"Ever wonder about the genesis of a startup Join Unboxing Biotech & guest @Spectral_MDAI founder & chairman Dr J Michael DiMaio to reminisce about the early days of $MDAI & the path to today. https://youtu.be/78QfQS3p5j8 https://youtu.be/78QfQS3p5j8"  
[X Link](https://x.com/vanjohn10/status/1962869626619985987)  2025-09-02T13:26Z [----] followers, [---] engagements


"@Protalix_Bio to attend HC Wainwright Global Investment Conference 8-10Sep in NY. CEO Dror Bashan available for 1:1 meetings. $PLX https://finance.yahoo.com/news/protalix-biotherapeutics-present-h-c-105000084.html https://finance.yahoo.com/news/protalix-biotherapeutics-present-h-c-105000084.html"  
[X Link](https://x.com/vanjohn10/status/1963221790349496719)  2025-09-03T12:45Z [----] followers, [--] engagements


"@LantheusNews to present @ Morgan Stanley Global Healthcare Conference *7 am ET on 9Sep *Webcast available $LNTH https://finance.yahoo.com/news/lantheus-present-morgan-stanley-23rd-123000862.html https://finance.yahoo.com/news/lantheus-present-morgan-stanley-23rd-123000862.html"  
[X Link](https://x.com/vanjohn10/status/1963222251496517781)  2025-09-03T12:47Z [----] followers, [--] engagements


"Dr. J. Michael DiMaio the Chairman of the Spectral AI board looks at DeepView's capabilities and how it can help providers better diagnose burns. $MDAI"  
[X Link](https://x.com/vanjohn10/status/1963954060106645672)  2025-09-05T13:15Z [----] followers, [---] engagements


"#ICYMI Spectral AI founder & chairman Dr J Michael DiMaio explains what to expect after #FDA DeepView clearance. $MDAI"  
[X Link](https://x.com/vanjohn10/status/1965064601978191903)  2025-09-08T14:48Z [----] followers, [---] engagements


"@Spectral_MDAI's DeepView featured in [--] presentations @ the European Burns Association conference held 3-6Sep. $MDAI https://finance.yahoo.com/news/deepview-system-highlighted-european-burns-120000410.html https://finance.yahoo.com/news/deepview-system-highlighted-european-burns-120000410.html"  
[X Link](https://x.com/vanjohn10/status/1965845756872626370)  2025-09-10T18:32Z [----] followers, [--] engagements


"FORCE Family Office invited us to speak with Acuamark Diagnostics Inc's CEO Bernard Peperstraete. In this clip he compares the relative accuracy rates of other cancer diagnostics compared to Acuamarks test. #methylation #Diagnostics #MedTech"  
[X Link](https://x.com/vanjohn10/status/1966568599180423203)  2025-09-12T18:24Z [----] followers, [--] engagements


"@AcuamarkDx's Founder & CEO Bernard Peperstraete discusses the upcoming Series B round what it will fund and the milestones associated with it. #methylation #Diagnostics #MedTech #HealthTech #Laboratory"  
[X Link](https://x.com/vanjohn10/status/1966874677654991298)  2025-09-13T14:40Z [----] followers, [--] engagements


"@AcuamarkDx's Founder & CEO Bernard Peperstraete responds to Johns question about M&A in the cancer diagnostic space. #methylation #Diagnostics #MedicalDiagnostics #LabTesting #Healthcare #MedicalTesting #DiagnosticServices #MedTech #HealthTech #Laboratory"  
[X Link](https://x.com/vanjohn10/status/1967868828991504534)  2025-09-16T08:31Z [----] followers, [--] engagements


"@Spectral_MDAI named to TIME's list of top [---] HealthTech companies. Ranking can be seen @ $MDAI https://finance.yahoo.com/news/spectral-ai-named-time-list-120000705.html http://time.com https://finance.yahoo.com/news/spectral-ai-named-time-list-120000705.html http://time.com"  
[X Link](https://x.com/vanjohn10/status/1969032083583434948)  2025-09-19T13:33Z [----] followers, [--] engagements


"@Geovax_News' greater productivity of its MVA vaccine platform supports its use in the United States and developing regions. CEO David Dodd explains. $GOVX #biotech #biotechnology #science #vaccine"  
[X Link](https://x.com/vanjohn10/status/1969047587530408352)  2025-09-19T14:35Z [----] followers, [--] engagements


"@LexariaBioCorp CEO Rich Christopher summarizes details from $LEXX human clinical trials evaluating #DehydraTECH & GLP1 agonists along with the technologys key benefits. #LexariaBioscience #LexariaDelivery #NextGenDrugDelivery #OralDeliveryTech #OralPeptideDelivery #GLP1Therapy #GLP1Agonist"  
[X Link](https://x.com/vanjohn10/status/1975297581677760631)  2025-10-06T20:30Z [----] followers, [---] engagements


"4 Dividend Stocks That Likely Could Survive a Market Crash - $T $CL $ KO $NEE http://buff.ly/2dqTCNi http://buff.ly/2dqTCNi"  
[X Link](https://x.com/vanjohn10/status/782686100326326272)  2016-10-02T20:58Z [----] followers, [--] engagements


"3 Red-Hot Tech Stocks: Back From the Dead and Going Much Higher $TXN $VMW $WDC http://buff.ly/2esPuNR http://buff.ly/2esPuNR"  
[X Link](https://x.com/vanjohn10/status/794146925868158976)  2016-11-03T11:59Z [----] followers, [--] engagements


"Advanced Micro Devices Inc. and NVIDIA Corporation Where's the Discount $AMD $NVDA http://buff.ly/2f1BOtH http://buff.ly/2f1BOtH"  
[X Link](https://x.com/vanjohn10/status/796336297593946113)  2016-11-09T12:59Z [----] followers, [--] engagements


"Watch These [--] Huge Put Purchases In Friday Trade $WUBA $THC $PRU $HIMX $FSLR http://buff.ly/2etfyrm http://buff.ly/2etfyrm"  
[X Link](https://x.com/vanjohn10/status/797864372173504513)  2016-11-13T18:11Z [----] followers, [--] engagements


"Depomed Buyout Rumors Trigger Possible Short Squeeze $DEPO $KKR http://buff.ly/2hXUcJj http://buff.ly/2hXUcJj"  
[X Link](https://x.com/vanjohn10/status/823003035542650881)  2017-01-22T03:03Z [----] followers, [--] engagements


"New President and Chief Operating Officer #biotech $NBIX @DavidBautz http://buff.ly/2i1DKHY http://buff.ly/2i1DKHY"  
[X Link](https://x.com/vanjohn10/status/823727793066348544)  2017-01-24T03:03Z [----] followers, [--] engagements


"Adcomm Meeting for Ingrezza Cancelled by FDA #biotech $NBIX @DavidBautz http://buff.ly/2icDJzv http://buff.ly/2icDJzv"  
[X Link](https://x.com/vanjohn10/status/824714784809644032)  2017-01-26T20:25Z [----] followers, [--] engagements


"Opinion: We're in the year of the biotech buyout and here are five prime targets $SPX $ARIA #investor http://buff.ly/2k56uiR http://buff.ly/2k56uiR"  
[X Link](https://x.com/vanjohn10/status/827999700351643648)  2017-02-04T21:58Z [----] followers, [--] engagements


"Hormel Foods Corp. Dividend Stock Analysis #foodproduction $HRL http://buff.ly/2jBpIcO http://buff.ly/2jBpIcO"  
[X Link](https://x.com/vanjohn10/status/828338681824030721)  2017-02-05T20:25Z [----] followers, [--] engagements


"Focus Fully Back On QuantaFlo Which Turns In Very Strong Quarter #biotech $SMLR @bmarckxCFA http://buff.ly/2khfHm8 http://buff.ly/2khfHm8"  
[X Link](https://x.com/vanjohn10/status/830130474286776320)  2017-02-10T19:05Z [----] followers, [--] engagements


"Dunnedin Ventures identifies Au belt at Kahuna project $DVI #gold http://buff.ly/2km7qxs http://buff.ly/2km7qxs"  
[X Link](https://x.com/vanjohn10/status/830400748492046336)  2017-02-11T12:59Z [----] followers, [--] engagements


"A Shifting Market Disrupts Under Armour's Growth Agenda; Analyst Reiterates Buy $UAA #Market http://buff.ly/2jBAMup http://buff.ly/2jBAMup"  
[X Link](https://x.com/vanjohn10/status/830763135875301377)  2017-02-12T12:59Z [----] followers, [--] engagements


"Metal Purchase Agreement with RIVI Capital #Minerals $GOD @RalstonCFA @goldendawninc http://buff.ly/2ksMExK http://buff.ly/2ksMExK"  
[X Link](https://x.com/vanjohn10/status/831942413199499267)  2017-02-15T19:05Z [----] followers, [--] engagements


"Third Quarter Revenue Growth Ahead of Expectations; Increase in Depreciation hits Earnings #transportation $UHAL http://buff.ly/2khqiRv http://buff.ly/2khqiRv"  
[X Link](https://x.com/vanjohn10/status/833708303314276355)  2017-02-20T16:02Z [----] followers, [--] engagements


"Listen to our biotech discussion on recent trends valuation $ONC and $TTNP. http://www.wfn1.com/interviews/radio-interviews/radio-archives/john-vandermosten-from-zacks-small-cap-research-on-ceo-money/ http://www.wfn1.com/interviews/radio-interviews/radio-archives/john-vandermosten-from-zacks-small-cap-research-on-ceo-money/"  
[X Link](https://x.com/vanjohn10/status/920473759978545152)  2017-10-18T02:17Z [----] followers, [--] engagements


"$SCLP to collaborate with BioNTech for T-cell receptor cancer treatments. https://www.scancell.co.uk/news/regulatory-news/scancell-to-collaborate-with-biontech https://www.scancell.co.uk/news/regulatory-news/scancell-to-collaborate-with-biontech"  
[X Link](https://x.com/vanjohn10/status/950713875586011137)  2018-01-09T13:00Z [----] followers, [--] engagements


"$UTHR to acquire $STDY in $216 MM deal. $STDY is developing Trevyent which will advance treprostinil for PAH. https://finance.yahoo.com/news/united-therapeutics-acquire-steadymed-ltd-100000172.html https://finance.yahoo.com/news/united-therapeutics-acquire-steadymed-ltd-100000172.html"  
[X Link](https://x.com/vanjohn10/status/991289807803428864)  2018-05-01T12:14Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing